IRIS

Sfoglia per Autore  

Opzioni
Mostrati risultati da 41 a 60 di 360
Titolo Data di pubblicazione Autore(i) File
New strategies and drugs in the salvage therapy for HIV infection 1-gen-2002 Quiros-Roldan, E; Torti, C; Pan, A; Carosi, G
Effectiveness of adjunctive gabapentin in resistant bipolar disorder: Is it due to anxious-alcohol abuse comorbidity? 1-gen-2002 Perugi, G; Toni, C; Frare, F; Ruffolo, G; Moretti, L; Torti, C; Akiskal, Hs
Long-term immunological benefit in patients with discordant responses to therapy depends on both level of viremia and duration of rebound 1-gen-2002 Tomasoni, L; Patroni, A; Uccelli, Mc; Gargiulo, F; Torti, C; Carosi, G; Castelli, F
Genetic differentiation, gene flow and the origin of infestations of the medfly, Ceratitis capitata 1-gen-2002 Gasperi, G; Bonizzoni, M; Gomulski, Lm; Murelli, V; Torti, C; Malacrida, Ar; Guglielmino, Cr
Genotypic resistance tests in the menagement of the HIV-infectet patient at virological failure 1-gen-2003 Aceti A; CAROSI, ; Giampiero;, Torti; Torti, Carlo
Analisi estensiva di sequenza dei geni della trascrittasi inversa e della proteasi di HIV-1 in una coorte clinica di pazienti HIV positivi NAIVE per la terapia antiretrovirale. 1-gen-2003 Torti, Carlo; Carlo; BONO L., ; QUIROS ROLDAN; Maria Eugenia; TIRELLI V. ; UCCELLI M. C. ; GIOVANNELLI G. ; FORLEO A. ; GARGIULO F., ; PERANDIN; Francesca; DE, Francesco; Maria Antonia;, Manca; Nino;, Carosi; Giampiero,
The prevalence of reduced zidovudine susceptibility in zidovudine-naive, antiretroviral-experienced HIV-1-infected patients 1-gen-2003 Gilleece Y; TORTI, ; Torti, Carlo
Comparison between rule-based HIV-1 genotype interpretation systems and phenotype driven systems: concordance analysis and correlation with clinical outcome in heavily treated patients 1-gen-2003 Torti, Carlo; Carlo; QUIROS, Roldan; Maria Eugenia; Keulen W; Scudeller L; Lo Caputo S; Boucher C;, Castelli; Francesco; Mazzotta F; Pierotti P; Been Tiktak AM; Buccoliero G; De Gennaro M;, Carosi; Giampiero; Tinelli C; GenPherex Study Group of the MaSTeR, Cohort
Characterisation of viro-immunlogical responses in a closely followed cohort oh heavily pretreated patients: evidence from the GenPheRex Study 1-gen-2003 Torti, Carlo; Carlo; QUIROS, Roldan; Maria Eugenia; SCUDELLER L; LO CAPUTO S; TOMASONI L;, Castelli; Francesco; POGGIO A; DELLE FOGLIE P; CHIRIANNI A; SIGHINOLFI L; MAZZOTTA F;, Carosi; Giampiero; THE GENPHEREX GROUP OF THE MASTER, Cohort
Theme 1 - Genotypic resistance tests in the management of the HIV-infected patient at virological failure 1-gen-2003 Aceti, A; Carosi, G; Torti, C
Severe hepatotoxicity during combination antiretroviral treatment: Incidence, liver histology, and outcome 1-gen-2003 Puoti, M; Torti, C; Ripamonti, D; Castelli, F; Zaltron, S; Zanini, B; Spinetti, A; Putzolu, V; Casari, S; Tomasoni, L; Quiros-Roldan, E; Favret, T; Berchich, L; Grigolato, T; Callea, F; Carosi, G
Modifications of health resource-use in Italy after the introduction of highly active antiretroviral therapy (HAART) for human immunodeficiency virus (HIV) infection. Pharmacoeconomic implications in a population-based setting 1-gen-2003 Casari, S; Palvarini, L; Quiros-Roldan, E; Moretti, F; Leone, L; Patroni, A; Castelli, F; Ripamonti, D; Tramarin, A; Carosi, G; Torti, Carlo
Persistence of HIV-1 drug resistance mutations and emergence during antiretroviral treatment interruption: considerations from a clinical case 1-gen-2003 Torti, Carlo; Carlo; Moretti F; Uccelli MC;, Tirelli; Valeria; QUIROS, Roldan; Maria Eugenia; Gargiulo F;, Carosi; Giampiero,
Bcl-2 expression is moderately correlated with long-term variability of CD4 T-cell increase under successful highly active antiretroviral therapy 1-gen-2003 Uccelli, Mc; Torti, C; Quiros-Roldan, E; Tinelli, C; Patroni, A; Castelli, F; Carosi, G; Airo, P
HIV/HTLV co-infection: frequency and epidemiological characteristics among patients admitted to an Italian hospital 1-gen-2003 Maria Eugenia; Moretti F;, Torti; Giampiero, ; Quiros-Roldan, E; Moretti, F; Torti, C; Casari, S; Castelli, F; Beltrame, A; Carosi, G
Predictors of long-term immunological outcome in rebounding patients on protease inhibitor-based HAART after initial successful virologic suppression: Implications for timing to switch 1-gen-2003 Tomasoni, Lr; Patroni, A; Torti, C; Paraninfo, G; Gargiulo, F; Quiros-Roldan, E; Uccelli, Mc; Airo, P; Tinelli, C; Carosi, G; Castelli, F
Comparison between rules-based human immunodeficiency virus type 1 genotype interpretations and real or virtual phenotype: Concordance analysis and correlation with clinical outcome in heavily treated patients 1-gen-2003 Torti, C; Quiros-Roldan, E; Keulen, W; Scudeller, L; Lo Caputo, S; Boucher, C; Castelli, F; Mazzotta, F; Pierotti, P; Been-Tiktak, Am; Buccoliero, G; De Gennaro, M; Carosi, G; Tinelli, C
HIV susceptibility to amprenavir: phenotype-based versus rules-based interpretations 1-gen-2003 Scudeller, L; Torti, C; Quiros-Roldan, E; Patroni, A; Lo Caputo, S; Moretti, F; Mazzotta, F; Donati, E; Vivarelli, A; Carosi, G
Benefit of higher closed-loop bandwidths in ocular adaptive optics 1-gen-2003 Diaz-Santana, L; Torti, C; Munro, I; Gasson, P; Dainty, C
Polymorphic immune restoration syndrome after effective HAART 1-gen-2003 Quiros-Rolden, E; Torti, C; Casari, S; Moretti, F; Puoti, M; Carosi, G; Bercich, L
Mostrati risultati da 41 a 60 di 360
Legenda icone

  •  file ad accesso aperto
  •  file disponibili sulla rete interna
  •  file disponibili agli utenti autorizzati
  •  file disponibili solo agli amministratori
  •  file sotto embargo
  •  nessun file disponibile